Regulatory
Published the 25 August 2020Continued sales growth despite Covid-19 shutdowns in the UK and Germany FIRST HALF OF THE YEAR (January-June) · The company’s sales amounted to 873 (218) KSEK. · Operating costs amounted to 8,300 (6,333) KSEK. · Result before and after tax amounted to -7,545 (-6,116)...
Regulatory
Published the 14 April 2020Invent Medic Sweden AB today presents the Annual Report for 2019 and the Proposal for Decision for the upcoming Annual General Meeting on May 5, 2020 in Lund. CEO Karin Bryder summarises the year 2019 was characterised by a commercial breakthrough for Invent Medic’s...
Regulatory
Published the 12 February 2020The Board of Directors and the CEO reports the following for the fiscal year 2019. Unless otherwise stated, all amounts are reported in integers SEK (SEK). Data in parentheses refer to the previous year. Strong fourth quarter with the first order for Efemia from a...
Regulatory
Published the 31 October 2019CEO Karin Bryder summarizes the quarter During the third quarter of 2019, we have spent alot of time on preparing the launches of efemia inthe UK and Germany which are taking place nowin the fourth quarter. Among other things, we havedelivered the first product...
Regulatory
Published the 22 August 2019SECOND QUARTER (April – June 2019) The company’s sales amounted to 101 (0) KSEK. Work capitalised by the company for its own use amounted to 0 (187) KSEK. Operating costs amounted to 3,243 (2,043) KSEK. Result after tax amounted to -3,143 (-1,857) KSEK....
